About Shanghai Doning Biotechnology
Shanghai Doning Biotechnology is a company based in Shanghai (China) founded in 2005.. Shanghai Doning Biotechnology has raised $14.88 million across 3 funding rounds from investors including GL Capital, HongShan and Ally Bridge Group. Shanghai Doning Biotechnology has completed 1 acquisition, including PreFluid. Shanghai Doning Biotechnology operates in a competitive market with competitors including Bio Rad, Siemens Healthineers, Merck, Quanterix and Biocare Medical, among others.
- Headquarter Shanghai, China
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$14.88 M (USD)
in 3 rounds
-
Latest Funding Round
-
Investors
GL Capital
& 2 more
-
Employee Count
Employee Count
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Shanghai Doning Biotechnology
Shanghai Doning Biotechnology has successfully raised a total of $14.88M across 3 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Last Round
- First Round First Round
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2021 | Amount | Series C - Shanghai Doning Biotechnology | Valuation | Gl-investment , HongShan |
|
| Apr, 2019 | Amount | Series A - Shanghai Doning Biotechnology | Valuation | Ally Bridge Group |
|
| Sep, 2018 | Amount | Seed - Shanghai Doning Biotechnology | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Shanghai Doning Biotechnology
Shanghai Doning Biotechnology has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include GL Capital, HongShan and Ally Bridge Group. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity and hedge fund investments in healthcare are managed.
|
Founded Year | Domain | Location | |
|
GL Capital is focused on healthcare sector value investments.
|
Founded Year | Domain | Location | |
|
HongShan is engaged in venture capital investments for innovative companies.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Shanghai Doning Biotechnology
Shanghai Doning Biotechnology has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include PreFluid. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Peristaltic pump solutions are supplied to pharmaceutical and chemical sectors.
|
2007 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Shanghai Doning Biotechnology
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Shanghai Doning Biotechnology Comparisons
Competitors of Shanghai Doning Biotechnology
Shanghai Doning Biotechnology operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Bio Rad, Siemens Healthineers, Merck, Quanterix and Biocare Medical, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Portfolio of products and services for life science research and clinical diagnostic markets
|
|
| domain | founded_year | HQ Location |
AI-based medical diagnostics are developed for healthcare applications.
|
|
| domain | founded_year | HQ Location |
Merck is engaged in science and technology solutions globally.
|
|
| domain | founded_year | HQ Location |
Assay kits for ultra-sensitive biomarker detection are developed.
|
|
| domain | founded_year | HQ Location |
Primary antibodies and instruments for immunohistochemistry are manufactured.
|
|
| domain | founded_year | HQ Location |
Tissue hypothermic storage and cryopreservation freeze media are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Shanghai Doning Biotechnology
Frequently Asked Questions about Shanghai Doning Biotechnology
When was Shanghai Doning Biotechnology founded?
Shanghai Doning Biotechnology was founded in 2005 and raised its 1st funding round 13 years after it was founded.
Where is Shanghai Doning Biotechnology located?
Shanghai Doning Biotechnology is headquartered in Shanghai, China.
Is Shanghai Doning Biotechnology a funded company?
Shanghai Doning Biotechnology is a funded company, having raised a total of $14.88M across 3 funding rounds to date.
What does Shanghai Doning Biotechnology do?
Shanghai Doning Biotechnology was founded in 2005 in Shanghai, China. Serum-free cell culture media is provided by the company to biopharmaceutical sectors. Operations focus on products such as basic medium, feed medium, cell therapy medium, and one-time solutions. Services encompass personalized media development, cell culture process optimization, and commissioned formula production for customers.
Who are the top competitors of Shanghai Doning Biotechnology?
Shanghai Doning Biotechnology's top competitors include Biocare Medical, Merck and Siemens Healthineers.
How many acquisitions has Shanghai Doning Biotechnology made?
Shanghai Doning Biotechnology has made 1 acquisition, including PreFluid.
Who are Shanghai Doning Biotechnology's investors?
Shanghai Doning Biotechnology has 3 investors. Key investors include GL Capital, HongShan, and Ally Bridge Group.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.